Foley Serves as IP Counsel to NantKwest in Record-Breaking Biotech IPO
11 August 2015
Foley helped NantKwest, Inc. (formerly known as Conkwest, Inc.) make history last week with an initial public offering (IPO) valuing the company at $2.6 billion, the highest ever IPO for a biotech company with no approved drugs.
Foley served as intellectual property counsel on the transaction and played a critical role in helping NantKwest develop a strong IP strategy and portfolio. Foley prepared more than 30 patent applications in advance of the client’s successful acquisition and IPO. The Foley team was led by Paul Stewart, Marc Morley, Simon Elliott, Jerry Swiss and Kristel Schorr.
People
Related News
24 April 2024
Press Releases
Nathaniel Lacktman Joins Tampa Bay Wave’s HealthTech|X Accelerator Advisory Council
Foley & Lardner LLP partner Nathaniel “Nate” Lacktman will serve as a member of the Advisory Council for Tampa Bay Wave’s inaugural HealthTech|X Accelerator program, an innovative initiative to support high-potential health technology startups ready to scale in Tampa and beyond.
22 April 2024
Press Releases
Foley Adds IP Partners Ngai Zhang and Drew Schulte, Enhancing Innovative Technology Capabilities
Foley & Lardner LLP announced today that it has bolstered its Innovative Technology Sector and Electronics Practice with the addition of partners Ngai Zhang and Drew Schulte in Washington, D.C. and Miami, respectively.
15 April 2024
Press Releases
Foley Names Andrew Wronski as Manufacturing Sector Chair
Foley & Lardner LLP is pleased to announce that Andrew “Andy” Wronski has been named chair of the firm’s Manufacturing Sector, effective April 15, 2024.